This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nair, H. B. Articles by Tekmal, R. R. Search for Related Content PubMed PubMed Citation Articles by Nair, H. B. Articles by Tekmal, R. R.

Induction of Aromatase Expression in Cervical Carcinomas: Effects of Endogenous Estrogen on Cervical Cancer Cell Proliferation

¹ Department of Gynecology and Obstetrics, University of Texas Health Science Center at San Antonio, San Antonio, Texas; ² Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, Georgia; and ³ Novartis Pharma AG, Basel, Switzerland

Requests for reprints: Rajeshwar Rao Tekmal, Department of Obstetrics and Gynecology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229. Phone: 210-567-4930; Fax: 210-567-4958; E-mail: tekmal{at}uthscsa.edu.

Epidemiologic studies have implicated estrogenic exposure as well as human papilloma virus (HPV) infection in cervical carcinogenesis, and some studies have suggested that estrogen and HPV may play synergistic roles in cervical tumorigenesis. In this study, we report a novel finding that 35% of cervical carcinomas tested (n = 19) express aromatase, the enzyme responsible for converting androgen to estrogen, the rate-limiting and final step in estrogen biosynthesis. On the other hand, no aromatase expression was detected in precancerous (n = 42) or normal cervical (n = 17) tissue samples. Increased aromatase was associated with increases in estrogen receptors (ER- and ER-ß) and a decrease in progesterone receptor levels, suggesting that in situ estrogen signaling via ER may be involved in tumor growth. Stable overexpression of aromatase in HPV⁺ cervical cancer cells resulted in increased cellular proliferation, anchorage-independent growth, and ER expression and activity. In contrast, little change in ER was observed in HPV^– cells. Steroid hormone receptor expression observed in vitro paralleled that seen in cervical carcinomas expressing aromatase. Aromatase overexpression also induced the expression of cyclin D1, proliferating cell nuclear antigen, and the HPV oncogenes, E6 and E7. Furthermore, the data underscores the importance of steroid receptor (estrogen and progesterone receptors) regulation in cervical carcinogenesis. To our knowledge, this is the first report demonstrating the induction of aromatase expression in cervical carcinomas, and opens the possibility that aromatase inhibitors may be potential therapeutic agents in cervical carcinomas expressing aromatase.

This article has been cited by other articles:

				L. Diaz, I. Ceja-Ochoa, I. Restrepo-Angulo, F. Larrea, E. Avila-Chavez, R. Garcia-Becerra, E. Borja-Cacho, D. Barrera, E. Ahumada, P. Gariglio, et al. Estrogens and Human Papilloma Virus Oncogenes Regulate Human Ether-a-go-go-1 Potassium Channel Expression Cancer Res., April 15, 2009; 69(8): 3300 - 3307. [Abstract] [Full Text] [PDF]

				R. T. Chlebowski, R. Prentice, M. Serati, S. Uccella, P. Bolis, S. R. Cummings, and V. Stathopolous Tibolone in Older Postmenopausal Women N. Engl. J. Med., November 13, 2008; 359(20): 2172 - 2173. [Full Text] [PDF]